Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 127,881 | 128,356 | 127,571 | 125,966 | 120,898 |
| Cost of Goods | 100,295 | 101,528 | 99,816 | 98,930 | 97,957 |
| Gross Profit | 27,586 | 26,828 | 27,755 | 27,036 | 22,941 |
| Operating Expenses | 8,975 | 20,875 | 12,953 | 13,321 | 12,246 |
| Operating Income | 18,906 | 6,481 | 15,618 | 14,645 | 11,652 |
| Interest Expense | 3,236 | 3,429 | 3,081 | 3,138 | 2,707 |
| Pre-tax Income | 15,670 | 3,052 | 12,537 | 11,507 | 8,945 |
| Income Tax | -7,259 | 610 | 5,847 | 3,856 | 1,789 |
| Net Income Continuous | 22,929 | 2,442 | 6,690 | 7,651 | 7,156 |
| Minority Interests | 83 | 69 | -61 | 127 | 90 |
| Net Income | $22,846 | $2,373 | $6,751 | $7,524 | $7,066 |
| EPS Basic Total Ops | 0.49 | 0.05 | 0.15 | 0.16 | 0.15 |
| EPS Basic Continuous Ops | 0.49 | 0.05 | 0.14 | 0.17 | 0.15 |
| EPS Diluted Total Ops | 0.48 | 0.05 | 0.15 | 0.16 | 0.15 |
| EPS Diluted Continuous Ops | 0.48 | 0.05 | 0.15 | 0.16 | 0.15 |
| EBITDA(a) | $22,843 | $10,525 | $19,691 | $18,816 | $16,012 |